CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5.Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. The rise in the need for cost-effective drug discovery and development
4.1.2. Growing genomic research activities for studying diseases
4.1.3. Advances in biobanking and the growing trend of conserving cord blood stem cells of
newborns
4.2. Market Restraints & Challenges
4.2.1. The high cost of automation
4.2.2. Long-term sustainability of biobanks
4.3. Market Opportunities
4.3.1. Emerging countries
4.3.2. Issues related to biospecimen sample procurement
CHAPTER 5. GLOBAL BIOBANKING MARKET– BY SAMPLE TYPE
5.1. Introduction
5.2. Blood Products
5.3. Human Tissues
5.4. Cell Lines
5.5. Nucleic Acids
5.6. Biological Fluids
5.7. Human Waste Products
CHAPTER 6. GLOBAL BIOBANKING MARKET– BY PRODUCTS & SERVICES
6.1 Introduction
6.2. Equipment
6.2.1. Storage Equipment
6.2.2. Sample Analysis Equipment
6.2.3. Sample Processing Equipment
6.2.4. Sample Transport Equipment
6.3. Consumables
6.3.1. Storage Consumables
6.3.2. Analysis Consumables
6.3.3. Processing Consumables
6.3.4. Collection Consumables
6.4. Services
6.4.1. Storage Services
6.4.2. Processing Services
6.4.3. Transport Services
6.4.4. Supply Services
6.5. Software
CHAPTER 7. GLOBAL BIOBANKING MARKET– BY STORAGE TYPE
7.1. Introduction
7.2. Manual Storage
7.3. Automated Storage
CHAPTER 8. GLOBAL BIOBANKING MARKET– BY APPLICATION
8.1. Introduction
8.2. Regenerative Medicine
8.3. Life Science Research
CHAPTER 9. GLOBAL BIOBANKING MARKET- BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. The U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL BIOBANKING MARKET- COMPANY PROFILES
10.1. Promega Corporation
10.2. Chart Industries, Inc.
10.3. VWR Corporation
10.4. Qiagen N.V.
10.5. Merck KGaA
10.6. Thermo Fisher Scientific Inc.
10.7. Tecan Trading AG
10.8. Brooks Automation, Inc.
10.9. Becton, Dickinson and Company
10.10. Hamilton Company
10.11. Greiner Holding AG
10.12. Panasonic Healthcare Holdings Co., Ltd.
CHAPTER 11. GLOBAL BIOBANKING MARKET- COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
